Medlive Technology Co., Ltd.

As of December 31, 2025, Medlive Technology Co., Ltd. carries a market capitalization of 7.15B, placing it among publicly traded companies globally. Its enterprise value stands at 3.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medlive Technology Co., Ltd.'s next confirmed earnings release is scheduled for March 29, 2027.

As of December 31, 2025, Medlive Technology Co., Ltd. has 737.03M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Medlive Technology Co., Ltd. maintains a current ratio of 19.09, meaning it holds 19.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Medlive Technology Co., Ltd.'s stock has declined approximately 46.60% over the past 52 weeks. The 50-day moving average sits at 7.05, while the 200-day moving average is 8.31.

As of December 31, 2025, Medlive Technology Co., Ltd. holds 4.14B in cash and equivalents against 11.25M in total debt, resulting in a net debt position of -2.86B. Total book value stands at 5.41B, with working capital of 4.21B providing operational flexibility.